# PCBD1

## Overview
PCBD1 is a gene that encodes the protein pterin-4 alpha-carbinolamine dehydratase 1, which is a bifunctional enzyme involved in critical metabolic and regulatory pathways. This protein plays a significant role in the tetrahydrobiopterin (BH4) regeneration pathway, acting as a dehydratase to facilitate the conversion of 4a-hydroxytetrahydrobiopterin to quinonoid dihydrobiopterin, essential for neurotransmitter synthesis and phenylalanine metabolism (Himmelreich2021Molecular). Additionally, PCBD1 functions as a dimerization cofactor for hepatocyte nuclear factor 1α (HNF-1α), enhancing its transcriptional activity and influencing gene expression in various tissues (Himmelreich2021Molecular). Mutations in the PCBD1 gene can lead to metabolic disorders such as transient hyperphenylalaninemia and early-onset non-autoimmune diabetes, highlighting its clinical significance (Ferrè2018New; ClaverieMartin2021Hereditary).

## Function
The PCBD1 gene encodes a bi-functional protein that plays a crucial role in the tetrahydrobiopterin (BH4) regeneration pathway. In healthy human cells, PCBD1 functions as a dehydratase, catalyzing the conversion of 4a-hydroxytetrahydrobiopterin to quinonoid dihydrobiopterin, which is essential for the regeneration of BH4. This cofactor is critical for the degradation of L-phenylalanine and the biosynthesis of monoamine neurotransmitters such as dopamine and serotonin (Himmelreich2021Molecular).

PCBD1 also acts as a dimerization cofactor for hepatocyte nuclear factor 1α (HNF-1α) in the nucleus, enhancing transcriptional activity and influencing gene expression (Himmelreich2021Molecular). This interaction is important for transcriptional regulation, impacting various cellular processes. The protein is active in both the cytoplasm and nucleus, playing a significant role in neurotransmitter synthesis and phenylalanine metabolism (Himmelreich2021Molecular).

Defects in PCBD1 can lead to BH4 deficiency, which is associated with hyperphenylalaninemia (HPA) and can result in mild metabolic phenotypes, including transient HPA, early-onset non-autoimmune diabetes, hypomagnesemia, and renal magnesium waste (Himmelreich2021Molecular).

## Clinical Significance
Mutations in the PCBD1 gene are associated with transient neonatal hyperphenylalaninemia and primapterinuria, an autosomal recessive disorder. This condition is characterized by mild transient hyperphenylalaninemia and elevated urinary levels of 7-biopterin. Affected individuals are typically asymptomatic and exhibit normal psychomotor development. However, follow-up studies have shown that patients may develop hypomagnesemia with renal magnesium wasting and maturity-onset diabetes of the young (MODY) type diabetes (Viering2016Genetic; ClaverieMartin2021Hereditary).

The PCBD1 gene encodes a bifunctional protein that acts as a coactivator of HNF1β-mediated transcription. Mutations in PCBD1 can lead to defective dimerization and degradation of the PCBD1 protein, resulting in decreased FXYD2 promoter activity. This reduction in FXYD2 expression causes hypomagnesemia in patients (ClaverieMartin2021Hereditary). Unlike patients with HNF1B mutations, those with PCBD1 mutations do not exhibit the CAKUT phenotype, which is attributed to different expression patterns (Viering2016Genetic).

PCBD1 mutations are also linked to MODY diabetes and renal magnesium wasting, highlighting its role as a dimerization cofactor for HNF-1β. Disruptions in the interaction between HNF-1β and PCBD1 may contribute to disease phenotypes (Ferrè2018New).

## Interactions
PCBD1, also known as pterin-4 alpha-carbinolamine dehydratase 1, is involved in several protein interactions, primarily acting as a coactivator for the transcription factor hepatocyte nuclear factor 1α (HNF1α). This interaction is crucial for enhancing the transcriptional activity of HNF1α, which is involved in the regulation of liver-specific gene expression. PCBD1 functions as a dimerization cofactor, stabilizing HNF1α homodimers and forming a tetrameric complex that facilitates the recruitment of transcriptional machinery, thereby enhancing gene transcription (Yu2007Proteomic).

PCBD1's role extends beyond its enzymatic function in tetrahydrobiopterin (BH4) metabolism, as it also participates in the nuclear regulation of gene expression through its interaction with HNF1α. This interaction is significant for the transcriptional activation of genes necessary for the function of tissues such as the liver, kidney, intestine, and pancreas (Yu2007Proteomic). Variants in the PCBD1 gene can lead to reduced protein activity, affecting its interaction with HNF1α and potentially leading to metabolic disorders such as transient hyperphenylalaninemia and early-onset non-autoimmune diabetes (Himmelreich2021Molecular).


## References


[1. (Viering2016Genetic) Daan H. H. M Viering, Jeroen H. F. de Baaij, Stephen B. Walsh, Robert Kleta, and Detlef Bockenhauer. Genetic causes of hypomagnesemia, a clinical overview. Pediatric Nephrology, 32(7):1123–1135, May 2016. URL: http://dx.doi.org/10.1007/s00467-016-3416-3, doi:10.1007/s00467-016-3416-3. This article has 121 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00467-016-3416-3)

[2. (Yu2007Proteomic) Miao Yu, Jian Wang, Wei Li, Yan Zhi Yuan, Chang Yan Li, Xiao Hong Qian, Wang Xiang Xu, Yi Qun Zhan, and Xiao Ming Yang. Proteomic screen defines the hepatocyte nuclear factor 1α-binding partners and identifies hmgb1 as a new cofactor of hnf1α. Nucleic Acids Research, 36(4):1209–1219, December 2007. URL: http://dx.doi.org/10.1093/nar/gkm1131, doi:10.1093/nar/gkm1131. This article has 31 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkm1131)

[3. (Ferrè2018New) Silvia Ferrè and Peter Igarashi. New insights into the role of hnf-1β in kidney (patho)physiology. Pediatric Nephrology, 34(8):1325–1335, July 2018. URL: http://dx.doi.org/10.1007/s00467-018-3990-7, doi:10.1007/s00467-018-3990-7. This article has 65 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00467-018-3990-7)

[4. (Himmelreich2021Molecular) Nastassja Himmelreich, Nenad Blau, and Beat Thöny. Molecular and metabolic bases of tetrahydrobiopterin (bh4) deficiencies. Molecular Genetics and Metabolism, 133(2):123–136, June 2021. URL: http://dx.doi.org/10.1016/j.ymgme.2021.04.003, doi:10.1016/j.ymgme.2021.04.003. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ymgme.2021.04.003)

[5. (ClaverieMartin2021Hereditary) Felix Claverie-Martin, Ana Perdomo-Ramirez, and Victor Garcia-Nieto. Hereditary kidney diseases associated with hypomagnesemia. Kidney Research and Clinical Practice, 40(4):512–526, December 2021. URL: http://dx.doi.org/10.23876/j.krcp.21.112, doi:10.23876/j.krcp.21.112. This article has 5 citations.](https://doi.org/10.23876/j.krcp.21.112)